Drugs – Page 31 – Healthy Skeptic

Feb 22 2010

New York Times

By Kevin Roche Headlines No Comments

Dozens of “targeted” drugs are emerging from laboratories of pharmaceutical companies – putting them to their truest test falls to a small band of doctors running experimental drug trials

Feb 22 2010

New York Times

By Kevin Roche Headlines No Comments

Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month

Feb 18 2010

Pioneer Press

By Kevin Roche Headlines No Comments

Manufacturers of pacemakers, drug pumps and other implants could be latest industry due for overhaul, as FDA takes a reviews how devices are approved.

Feb 17 2010

EarthTimes

By Kevin Roche Headlines No Comments

Going Against the Tide of Rising Health Care Costs, Surescripts Announces Significant Price Reduction for E-Prescribing

Feb 17 2010

Bloomberg

By Kevin Roche Headlines No Comments

Lipitor and Crestor and rival drugs to lower cholesterol also boost diabetes rates by about 9 percent, according to a study that quantified a complication recently discovered

Feb 12 2010

New York Times

By Kevin Roche Headlines No Comments

Mr. Tauzin, president of the pharmaceutical industry’s trade group, resigned in the latest unexpected fallout of the Republican upset in the Massachusetts Senate race

Feb 10 2010

Washington Post

By Kevin Roche Headlines No Comments

Merck & Co. must appoint two new independent committees and a chief medical officer to monitor the safety of its medicines and drugs in development, under a proposed settlement

Feb 09 2010

Washington Post

By Kevin Roche Headlines No Comments

A bipartisan group of congressional members outlined a number of allegations against CVS Caremark – the group urged the FTC to investigate the company

Feb 09 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Now, AstraZeneca’s statin Crestor has crossed a new threshold: It’s the cholesterol drug for people who don’t have high cholesterol.

Jan 29 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Novartis agreement to settle allegations involving marketing of an epilepsy drug is the latest in a string of cases showing that improper marketing practices are still a problem

Jan 29 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

The chairman of the drug industry’s main trade group in the U.S. said the group “hasn’t withdrawn support” for the version of health-care reform passed by the Senate

Jan 27 2010

Washington Times

By Kevin Roche Headlines No Comments

A House panel on Wednesday will consider shining a light on White House deals made with special-interest groups during the push to pass a health care reform bill.

Jan 26 2010

Shifts in Drug Marketing Spending

By Kevin Roche Commentary No Comments

Pharmaceutical manufacturers have spent massive amounts of money on sending sales reps to visit individual physicians and on direct-to-consumer advertising, to the point that this spending is often larger than…

Read More

Jan 20 2010

Bloomberg

By Kevin Roche Headlines No Comments

Drugmakers’ shares posted the biggest gains in Asia and Europe today on speculation Obama’s plan to overhaul the health-care system will be derailed

Jan 19 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Despite years of effort to make medications safer medication errors cause at least one death every day and injure approximately 1.3 million people annually

© 2025 Healthy Skeptic.